AI assistant
Masterflex SE — Interim / Quarterly Report 2005
May 30, 2005
276_10-q_2005-05-30_321b3632-f113-444e-aada-c9ae6cbe811a.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
QUARTERLY REPORT 1/2005

Investor Relations
Stephanie Kniep Fon +49(0)209/97077-44 Fax +49(0)209/97077-20 E-mail: [email protected] www.masterflex.de
Masterflex AG Willy-Brandt-Allee 300 D-45891 Gelsenkirchen GERMANY
Fon +49(0)209/97077-0 Fax +49(0)209/97077-33
E-mail: [email protected] www.masterflex.de www.masterflex-bz.de
| ■ Revenue growth |
+7.6 % | |
|---|---|---|
| ■ EBIT |
+10.2 % | |
| ■ Net profit |
+23.0 % | |
| ■ Outlook for 2005 |
||
| Board confirms forecast: | ||
| Revenue | +15-20% | |
| EBIT | +15-25% | |
| March 31, 2005 | March 31, 2004 | +/- | |
|---|---|---|---|
| Revenue (a thou.) | 19,215 | 17,851 | 7.6 % |
| EBITDA (a thou.) | 2,801 | 2,724 | 2.8 % |
| EBIT (a thou.) | 2,307 | 2,094 | 10.2 % |
| EBT (a thou.) | 1,860 | 1,851 | 0.5 % |
| Net profit (a thou.) | 1,283 | 1,043 | 23.0 % |
| IFRS-Earnings per share (a) | 0.29 | 0.23 | 26.1 % |
| EBIT-Margin | 12.0 % | 11.7 % | 2.6 % |
| Net profit margin | 6.7 % | 5.8 % | 15.5 % |
| Number of employees | 475 | 419 | 13.4 % |
| March 31, 2005 | Dec 31, 2004 | +/- | |
| Equity (a thou.) | 30,225 | 31,968 | -5.5 % |
| Total assets (a thou.) | 82,466 | 83,573 | -1.3 % |
| Equity ratio | 36.7 % | 38.3 % | -4.2 % |
Stock development January 2005 - May 2005

Dear shareholders,
Masterflex AG successfully continued its steady revenue and earnings growth in Q1 2005. However, this development is not reflected in the year-on-year comparison due to the unusually strong first quarter in the previous year, when one-time factors led to the highest earnings growth in the Company's history. This development was also unusual given that, traditionally, growth is mainly generated in the second half of the year. However, the successful development can clearly be seen from a comparison with Q1 2003 (revenue +25.0%, EBIT +77.3%).
Consolidated revenue rose 7.6% year-on-year to EUR 19.2 million.This is due primarily to increasing contributions from the Medical Technology and Fuel Cell Technology business units. Earnings before interest, taxes, depreciation and amortization (EBITDA) rose 2.8% year-on-year in Q1 2005 to EUR 2.7 million; earnings before interest and taxes (EBIT) increased by 10.2% to EUR 2.3 million. The EBIT margin rose year-onyear to an excellent 12.0% - one of the best figures for any German listed company. Net profit rose by 23.0% to EUR 1.3 million. Earnings per share climbed as a result from EUR 0.23 to EUR 0.29 (+26.1%).
In Q1 2005, the innovative product portfolio and increasing internationalization in the High-tech Hose Systems business unit again contributed significantly to positive earnings development. In Medical Technology, the investments of the previous years are now bearing fruit. Positive earnings contributions have been generated since the end of 2004.Within the
Fuel Cell Technology business unit, the mobile office segment is experiencing extremely dynamic growth. We believe there is considerable additional potential here, which is why we acquired the remaining shares of DICOTA GmbH in February 2005. Novoplast Schlauch-

RESULTS
BUSINESS UNITS
technik GmbH is now also a 100% subsidiary.
The Board of Masterflex AG continues to see substantial growth potential, particularly with regard to new developments in the High-tech Hose Systems business area.We therefore confirm our forecasts for full-year 2005 of a growth in revenue of 15% to 20%, and an increase in EBIT of between 15% and 25%.
Income statement
The income statement as of March 31, 2005 shows that we are successfully focusing on the sale of innovative, premiumpriced products with high margins. Internationalization is also contributing to the positive development.
The ratio of cost of materials to revenue remained stable at 43.5% in Q1 2005 (previous year: 45.0 %), as did the staff costs ratio at 24.8% (previous year: 24.0%).The number of employees increased by 13.4% to 475.
The ratio of other operating expenses to revenue also remained roughly on a par with the prior-year level. The same applies to the depreciation and amortization expense which consisted primarily of depreciation and amortization of noncurrent assets.
As a result of these effects, net profit for the period (EBT) improved by 0.5% as of March 31, 2005, rising to EUR 1.86 million (previous year:EUR 1.85 million).Increasing earnings from our foreign subsidiaries in countries with low tax rates resulted in 23% growth in consolidated net profit, to EUR 1.3 million.
Changes in individual balance sheet items
Masterflex AG's net assets changed marginally as of March 31, 2005.Total assets fell by 1.3% to EUR 82.5 million.The yearon-year difference is due to a borrower's note loan of EUR 23 million that we received from IKB Deutsche Industriebank AG in summer of last year. The unused portion of this loan was invested in commercial papers in 2004 (see "Other securities" item). In February 2005, part was used to acquire the outstanding shares in DICOTA GmbH and Novoplast Schlauchtechnik GmbH. On the equity and liabilities side of the balance sheet, bank loans and overdrafts rose due to the borrower's note loan by EUR 19.1 million year-on-year.

As a result of the restructuring of the Company's equity and liabilities, the equity ratio fell year-on-year to 36.7% of total assets.
High-tech Hose Systems - continuing success
Our core business unit, High-tech Hose Systems, continued its successful development in Q1 2005. More and more customers are coming to appreciate the excellent performance and diversity of our products. Our high-performance material polyurethane is clearly superior to traditional materials such as PVC, rubber, and steel in many areas, such as abrasion resistance and weight.
We have successfully presented our product range at various German and international trade shows such as the BAUMA trade fair for construction machinery, the Hanover Fair,WIN in Turkey and INDUSTRIA in Hungary.
Our internationalization progressed as planned in Q1 2005. We will further expand our marketing and sales activities in Eastern Europe and in the USA to optimally develop these markets.We expect the North American market to play a substantially greater part in this business unit in the years to come. We will strengthen our export activities in the Asian market. For 2005, we therefore expect that the internationalization of our business will make substantial contributions to
BUSINESS UNITS
BUSINESS UNITS
revenue and earnings.
We view our innovative strength as another mainstay for dynamic growth. In Q1, we recorded successes in the development of a completely new generation of hoses.These hoses are given an inner coating with the aid of nanotechnology, which makes them impermeable to hydrogen.We believe that possible areas of application will be where stainless steel pipes are used today.The first plant is scheduled for completion in the summer and will begin production of these new hoses. This innovative coating process has been patented.
Medical Technology set-up of production and sales completed
In 2004, we turned the Medical Technology business unit around, generating a small contribution to earnings. Our goal for 2005 is to expand the contribution of this business unit to our positive development. We will expand our surgery kits business. MHC Medic Health Care GmbH was set up at the end of 2004 as a subsidiary of Angiokard Medizintechnik GmbH & Co. with the aim of establishing it as a brand for surgery kits. In Q1 2005, we laid the organizational foundations for expansion.
LaryVent, our globally patented respiratory mask, has been in the pre-marketing phase since the beginning of the year, in which it is being presented to doctors and hospitals. In addition, LaryVent is also designed for use in emergency medicine, where its excellent product qualities - ease of use and very low risk of injury - are of major significance.We expect to be able to make the first reliable statements on the product's market success at the end of the first half of 2005.
On the whole, we believe that Medical Technology offers considerable potential for the future. On the one hand, polyurethane, as a plasticizer-free alternative, is increasingly replacing problem materials in the medical sector, and can also be given antiseptic or antibacterial properties, for example. On the other, our products' reliable calculation base is in line with the trend for process orientation and process management. Economic considerations are playing an increasing role in procurement.We therefore expect substantial revenue and earnings contributions from our innovative product portfolio in the coming years.
Fuel Cell Technology a major hit at the Energy fair
We see major opportunities for our third business unit, Fuel Cell Technology. We share the experts' opinion that the breakthrough in this area will initially occur in niche markets, where the hydrogen infrastructure is being established as a stand-alone solution. This includes the market for electric bikes. Global sales of battery-powered electric bikes in 2004 already amounted to around one million units, of which around 120,000 were sold in Europe.These "pedelecs" automatically link the motor's output with the cyclist's muscle power via a force or movement sensor.The motor is therefore only activated while there is pressure on the pedals, and helps the rider by providing additional power. A first area of potential demand could be in municipalities and companies with large sites, where a self-contained infrastructure with a central filling station is possible.
A cooperation was concluded in January 2005 with Berlinbased Hawk Bikes E&M GmbH, a successful developer of specialized and customized bicycle applications. The aim of the cooperation is to develop three-wheeled cargo bikes (bikes for transporting small loads) equipped with Masterflex's fuel cells and an innovative drive concept.These cargo bikes were presented at the Hanover Fair in spring 2005, and met with an excellent response. The joint project is being co-financed by the European Regional Development Fund (ERDF) and the

State of North Rhine-Westphalia.
In general, our fuel cell projects receive political support on both a national and a European level. This will provide the basis for
INVESTOR RELATIONS
OUTLOOK
the introduction of fuel cell systems over a wide area. It was announced in March 2005 that the EU wants to give greater financial support to the production, storage and distribution of hydrogen.
In the short to medium term, our subsidiary DICOTA GmbH is driving the momentum in the area of Fuel Cell Technology. The company has positioned itself extremely successfully in the mobile office systems area in recent years. DICOTA aims to act as a sales channel in this dynamically growing market and hence promote the success of fuel cells in the future, particularly once a logistical infrastructure exists.We are expecting substantial growth potential, and therefore acquired the remaining shares of the company in February 2005.As in the other business units, the comparison with the prior-year period is distorted.The mobile office equipment segment recorded especially high growth in Q1 2004. DICOTA's business activities are normally concentrated on the end of the year.
Our forecasts take the mobile office business into account, but not fuel cell technology.We intend to spin off our operations in this area to a separate company over the course of the year.This is scheduled for H2 2005.
Investor relations and share price
Our investor relations can point to a number of successes in Q1 2005. We continued our international road show activities in February,further raising our profile.Masterflex AG also gave a presentation about itself in March at Commerzbank AG's international investor conference.
Additional research reports on Masterflex AG have appeared as a result of the Company's strong development and our increasing profile. The research house First Berlin, WestLB and Bankhaus Lampe all accompanied their coverage with buy recommendations in recent weeks. Other banks have also signaled interest, so that we expect further research reports to be published during the year.
This positive assessment of Masterflex AG was not reflected
in an increase in the Company's share price in early 2005. However, the shares' liquidity improved further on the back of the expansion of the free float at the beginning of the year.The free float currently amounts to 56.0%. DWS Luxemburg informed us at the beginning of the year that it holds 5.44% of our shares.
The goals for 2005 include the further internationalization of the investor base. Following the publication of the 2004 annual financial statements, a successful roadshow was held in Europe's financial centers from the end of April to mid-May. Additional discussions with investors and roadshows are planned for the rest of the year to increase awareness of Masterflex AG's successful business model on the capital markets.
Dividend increase of 33% planned
Since we want to continue to share our Company's successful development with our shareholders, the Board is again planning to pay a dividend. The proposal to be submitted to the Annual General Meeting provides for an increase of 33% to EUR 0.80 per share. The Annual General Meeting will take place in Schloss Horst in Gelsenkirchen (the same venue as last year) on June 8, 2005.
Outlook
The past fiscal year once again underscored Masterflex AG's successful business model. Revenue has grown every year since 1987, and we have consistently generated a profit. We are convinced that this development will continue in fiscal year 2005 - despite our slightly muted start. As previously mentioned, this is not due to economic blips or sales problems, but to one-time factors in the previous year.
We therefore reconfirm the forecast we issued in April. We base our positive estimate on our outstanding technological expertise, which has made us the recognized market leader, and our high innovative strength in our existing business units. In addition, we are establishing a new market with our fuel cell
NOTES
technology activities that has substantial long-term future potential.
As a result, we still expect revenue to rise by between 15% and 20% and EBIT by between 15% and 25% in 2005.
May 2005
Detlef Herzog Chairman of the Board
Ulrich Wantia Board member
Notes to the Quarterly Report
1.Accounting principles
This quarterly report was prepared in accordance with the International Financial Reporting Standards (IFRSs) and the International Accounting Standards (IASs) promulgated by the International Accounting Standards Board (IASB), and complies with the Company's key accounting principles as presented here.The accounting policies applied were the same as those applied in the preparation of the consolidated financial statements for the fiscal year ended December 31, 2004.
The new accounting standards from the IASB (International Accounting Standards Board) Improvements Project were applied with effect from January 1, 2005.
The main change in the Improvements Project affecting Masterflex relates to the revised IAS 1, which requires the reclassification of assets and liabilities in the balance sheet by maturity. The other changes do not have a material effect on the Group's net assets, financial position and results of operation.
2. Consolidated group
There were no changes to the consolidated group during Q1 2005 as against December 31, 2004.
3. Dividend
The Board of Masterflex AG will propose a 33% increase in the dividend as against the previous year to EUR 0.80 per share to the Annual General Meeting on June 8, 2005.
4. Segment reporting
Segment reporting is performed in accordance with IAS 14, with the primary segment reporting format being productrelated business units. Masterflex AG has three business units: High-tech Hose Systems (HTS), Medical Technology (MT), and Fuel Cell Technology (FCT).
HTS = High-Tech-Hose Systems MT = Medical Technology FCT = Fuel Cell Technology
| March 31, 2005 | HTS | MT | FCT | ment- aggregate |
Seg- Reconci- liation |
Group |
|---|---|---|---|---|---|---|
| a thou. | a thou. | a thou. | a thou. | a thou. | a thou. | |
| Revenue | 8,588 | 4,184 | 6,443 | 19,215 | 0 | 19,215 |
| Earnings (EBIT) | 1,773 | -98 | 908 | 2,583 | -276 | 2,307 |
| Investments in property, | ||||||
| plant and equipment and | ||||||
| intangible assets | 410 | 136 | 208 | 754 | 0 | 754 |
| Assets | 28,534 | 22,531 | 20,235 | 71,300 | 11,166 | 82,466 |
| Depreciation and | ||||||
| amortization | 331 | 135 | 28 | 494 | 0 | 494 |
| Liabilities | 6,456 | 2,307 | 4,530 | 13,293 | 38,948 | 52,241 |
NOTES
| CALENDAR |
|---|
| ---------- |
| March 31, 2004 | HTS | MT | FCT | ment- aggregate |
Seg- Reconci- liation |
Group |
|---|---|---|---|---|---|---|
| a thou. | a thou. | a thou. | a thou. | a thou. | a thou. | |
| Revenue | 8,989 | 3,299 | 5,563 | 17,851 | 0 | 17,851 |
| Earnings (EBIT) | 1,885 | -209 | 864 | 2,540 | -446 | 2,094 |
| Investments in property, | ||||||
| plant and equipment and | ||||||
| intangible assets | 350 | 85 | 15 | 450 | 0 | 450 |
| Assets | 28,489 | 17,487 | 9,539 | 55,515 | 6,986 | 62,501 |
| Depreciation and | ||||||
| amortization | 349 | 211 | 70 | 630 | 0 | 630 |
| Liabilities | 6,347 | 2,429 | 3,211 | 11,987 | 18,199 | 30,186 |
5. Earnings per share
In accordance with IAS 33, basic earnings per share are calculated by dividing the consolidated net profit by the weighted average of shares outstanding during the period under review. Earnings per share as of March 31, 2005 amounted to EUR 0.29 on the basis of a weighted average of 4.374.430 shares. Diluted earnings amounted to EUR 0.29. The stock option program (see page 67, section x of the 2004 Annual Report), which is taken into account in the calculation of diluted earnings per share, does not have any effect as the criteria for it have not been met.
6. Own shares
As of March 31, 2005 Masterflex AG held 154.973 own shares.There were no changes to the stock options and other subscription rights disclosed in the 2004 Annual Report during the period under review. Due to the increased number of own shares in the portfolio, equity declined slightly and now amounts to 36.7%.
7. Employees
At 475, the number of employees as of March 31, 2005 was up 13.4% on the prior-year period (419 employees).
March 2005
March 10-16, CEBIT (exhibitor: Dicota GmbH)
March 17-20,WIN Istanbul (exhibitor: Masterflex AG)
April 2005
April 11-15, Hannover fair (exhibitor: Masterflex AG, Novoplast Schlauchtechnik GmbH, Masterflex Brennstoffzellentechnik)
April 27,Annual Press Conference, presentation of the annual report 2004, Düsseldorf
April 28, DVFA-Analyst-Meeting, Frankfurt
May 2005
International road show
Quarterly report I/2005
May 24-27, Industria Budapest (exhibitor: Masterflex AG, Novoplast Schlauchtechnik GmbH)
June 2005
June 8, Annual General Meeting, Gelsenkirchen
August 2005 Quarterly report 2/2005
October 2005
11-13, Powtech Nuremberg (exhibitor: Masterflex AG)
November 2005
Eigenkapitalforum Frankfurt Quarterly report 3/2005
BALANCE SHEET - IFRS
BALANCE SHEET - IFRS
| ASSETS | Mar.31,2005* | Dec. 31,2004 |
|---|---|---|
| Ta | Ta | |
| NONCURRENT ASSETS | ||
| Intangible assets | 25,982 | 17,946 |
| Property, plant and equipment | 18,902 | 18,612 |
| Long-term investments | 1,006 | 2,391 |
| Deferred tax assets | 322 | 394 |
| 46,212 | 39,343 | |
| CURRENT ASSETS | ||
| Inventories | 15,502 | 13,804 |
| Prepaid expences | 857 | 639 |
| Trade accounts and notes receivable | 10,507 | 12,189 |
| Securities | 3,101 | 9,500 |
| Cash and bank balances | 6,287 | 8,098 |
| 36,254 | 44,230 | |
| Total assets | 82,466 | 83,573 |
* Unaudited
| EQUITY AND LIABILITIES | Mar.31.2005* Dec. 31,2004 Ta |
Ta | ||
|---|---|---|---|---|
| SHAREHOLDERS´ EQUITY | ||||
| Consolidated equity | 29,405 | 29,639 | ||
| Minority interest | 820 | 2,329 | ||
| Total equity | 30,225 | 31,968 | ||
| NONCURRENT LIABILITIES | ||||
| Provisions | 301 | 292 | ||
| Financial liabilities | 28,526 | 29,839 | ||
| Deferred income | 2,839 | 2,849 | ||
| Other noncurrent liabilities | 3,217 | 3,280 | ||
| Deferred tax liabilities | 2,113 | 2,194 | ||
| 36,996 | 38,454 | |||
| CURRENT LIABILITIES | ||||
| Provisions | 3,946 | 4,419 | ||
| Financial liabilities | 2,417 | 1,326 | ||
| Other current liabilities | 8,882 | 7,406 | ||
| 15,245 | 13,151 | |||
| Total equity and liabilities | 82,466 | 83,573 |
* Unaudited
INCOME STATEMENT - IFRS
CASH-FLOW - IFRS
| Financial statement as of | Jan.-March, 05* a thou. |
Jan.-March, 04* a thou. |
|---|---|---|
| Revenue | 19,215 | 17,851 |
| Changes in inventories of finished goods and work in progress |
-86 | 115 |
| Work performed by the enterprise | ||
| and capitalized | 61 | 42 |
| Other operating income | 510 | 111 |
| Gross revenue | 19,700 | 18,119 |
| Cost of materials | -8,330 | -8,024 |
| Staff costs | -4,767 | -4,306 |
| Depreciation and amortization expense |
-494 | -630 |
| Other operating expenses | -3,802 | -3,065 |
| Total operating expenses | -17,393 | -16,025 |
| Income from investments | 8 | 7 |
| Other interest and similar income | 215 | 22 |
| Write-downs of current financial instruments |
-160 | 0 |
| Interest and similar expenses | -510 | -272 |
| Profit before taxes | 1,860 | 1,851 |
| Income tax expense | -568 | -609 |
| Deferred taxes | 73 | -92 |
| Other taxes | -55 | -51 |
| Income attributable to minority | ||
| interests | -27 | -56 |
| Net profit for the period | 1,283 | 1,043 |
* Unaudited
| Financial statement as of | Mar. 31,2005* | Mar. 31,2004* |
|---|---|---|
| a thou. | a thou. | |
| Net profit for the period | 1,099 | 1,043 |
| Depreciation and amortization | ||
| expense | 494 | 630 |
| Change in provisions | -399 | 50 |
| Other non-cash expenses/income | ||
| and gain/loss on disposal of non | ||
| current assets | -38 | 11 |
| Changes in inventories, trade | ||
| receivables and other assets | 275 | -1,614 |
| Changes in trade payables and other | ||
| equity and liabilities | 1,376 | 2,381 |
| Net cash from/used in operating | ||
| activities | 2,807 | 2,501 |
| Proceeds from asset disposals | 1,372 | 32 |
| Payments to acquire noncurrent assets | -754 | -693 |
| Payments to acquire consolidated | ||
| subsidiaries | -8,324 | 0 |
| Net cash used in investing | ||
| activities | -7,706 | -661 |
| Proceeds from additions to equity | ||
| (capital increases, sales of treasury | ||
| shares) | 0 | 43 |
| Dividends paid to owners and | ||
| minority interests (dividends, | ||
| acquisition of treasury shares) | -3,252 | -374 |
| Proceeds from securities / | ||
| term deposits | 6,399 | 0 |
| Proceeds from finance facilities raised | 1,091 | 76 |
| Repayment of borrowings | -1,379 | -1,655 |
| Net cash from/used in financing | ||
| activities | 2,859 | -1,910 |
| Net change in cash and cash | ||
| equivalents | -2,040 | -70 |
| Changes in cash and cash equivalents | ||
| due to exchange rates and other | ||
| factors | 229 | 374 |
| Cash and cash equivalents at | ||
| beginning of period | 8,098 | 3,594 |
| Cash and cash equivalents at | ||
| end of period | 6,287 | 3,898 |
* Unaudited
CHANGES IN EQUITY CHANGES IN EQUITY
Consolidated statement of changes in equity
| Issued capital |
Share premium |
Retained earnings (retained profits brought forward) |
Revaluation reserve of financial instruments |
Exchange differences |
Total | |
|---|---|---|---|---|---|---|
| a thou. | a thou. | a thou. | a thou. | a thou. | a thou. | |
| Equity at December 31, 2003 | 4,498 | 20,663 | 5,625 | -559 | -1,035 | 29,192 |
| Net profit | 0 | 0 | 1,043 | 0 | 0 | 1,043 |
| Changes in fair values of financial instruments |
0 | 0 | 0 | -29 | 0 | -29 |
| Currency translation gains/losses from translation of foreign financial statements |
0 | 0 | 0 | 0 | 362 | 362 |
| Sale of treasury shares | 2 | 41 | 0 | 0 | 0 | 43 |
| Purchase of own shares | -11 | -222 | 0 | 0 | 0 | -233 |
| Dividend distributions | 0 | 0 | 0 | 0 | 0 | 0 |
| Translation differences from net investments in foreign entities* |
0 | 0 | 0 | 0 | 12 | 12 |
| Other changes | 0 | 0 | 40 | 0 | 0 | 40 |
| Equity at March 31, 2004 | 4,489 | 20,482 | 6,708 | -588 | -661 | 30,430 |
| Equity at December 31, 2004 | 4,411 | 18,519 | 8,960 | -671 | -1,580 | 29,639 |
| Net profit | 0 | 0 | 1,283 | 0 | 0 | 1,283 |
| Changes in fair values of financial instruments |
0 | 0 | 0 | -16 | 0 | -16 |
| Currency translation gains/losses from translation | ||||||
| of foreign financial statements | 0 | 0 | 0 | 0 | 229 | 229 |
| Sale of treasury shares | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchase of own shares | -66 | -1,650 | 0 | 0 | 0 | -1,716 |
| Dividend distributions | 0 | 0 | 0 | 0 | 0 | 0 |
| Translation differences from net investments in | ||||||
| foreign entities* | 0 | 0 | 0 | 0 | 0 | 0 |
| Other changes | 0 | 0 | -14 | 0 | 0 | -14 |
| Equity at March 31, 2005 | 4,345 | 16,869 | 10,229 | -687 | -1,351 | 29,405 |
*net of income tax effects